SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) went down by -2.37% from its latest closing price when compared to the 1-year high value of $2.46 and move down -1347.06%, while SLS stocks collected -8.33% of loss with the last five trading sessions.

SLS Market Performance

SLS stocks went down by -8.33% for the week, with the monthly jump of 18.71% and a quarterly performance of -82.26%, while its annual performance rate touched -84.58%. The simple moving average for the period of the last 20 days is 8.08% for SLS stocks with the simple moving average of -84.24% for the last 200 days.

Analysts’ Opinion on SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)

Many brokerage firms have already submitted their reports for SLS stocks, with Oppenheimer repeating the rating for SLS shares by setting it to “Outperform”. The predicted price for SLS socks in the upcoming period according to Oppenheimer is $14 based on the research report published on November 1, 2018.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see SLS stock at the price of $11. The rating they have provided for SLS stocks is “Buy” according to the report published on April 2, 2018.

Maxim Group gave “ Buy” rating to SLS stocks, setting the target price at $13 in the report published on March 19, 2018.

SLS Stocks -26.67% Far from 50 Day Moving Average

After a stumble in the market that brought SLS to its low price for the period of the last 52 weeks, SELLAS Life Sciences Group, Inc. was unable to take a rebound, for now settling with -93.29% of loss for the given period.

The stock volatility was left at 15.36%, however, within the period of a single month, the volatility rate increased by 9.68%, while the shares surge at the distance of +17.94% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -68.37% lower at the present time.

In the course of the last 5 trading sessions, SLS went down by -8.33%, which changed the moving average for the period of 200 days to the total of -87.69% of losses for the stock in comparison to the 20-day moving average settled at $0.15. In addition, SELLAS Life Sciences Group, Inc. saw -86.59% in overturn over the period of a single year with a tendency to cut further losses.